Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KDM3B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SNX3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYAT1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
PPP1R37 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PDCL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HSPB6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GJA4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ITGB3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FAM3A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
ME3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CHMP4A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GNAS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARL4D - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PAQR3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
F9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CDO1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RPP30 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ABI2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ANAPC5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on